Role of hepatic desaturases in obesity-related metabolic disorders
Authors:
- Ulf RisérusURUlf Risérus
- 1 November 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 13 (6) , 703-708
Abstract
This review aims to address the latest research on hepatic desaturases and metabolic disorders, with focus on stearoyl-CoA desaturase-1 (SCD-1) indices in observational studies. In animal studies, SCD-1 inhibition protects against features of the metabolic syndrome and is associated with improved hepatic insulin resistance and decreased steatosis. In human observational studies, higher estimated hepatic SCD-1 and Δ6-desaturase activities predict the metabolic syndrome, insulin resistance and mortality whereas Δ5-desaturase index is often inversely related. However, because the desaturase activities in the liver and adipose tissue may not be regulated in parallel, it is important to define used lipid fractions when comparing studies. It is also important to take the background diets of the populations into account when comparing studies. Moreover, there may be a divergence in desaturase regulation depending on glycaemic control among individuals. Increased SCD-1 indices reflecting liver desaturase activity have been associated with insulin resistance, fatty liver, the metabolic syndrome and mortality. However, it remains to be determined if high hepatic SCD-1 activity plays a direct role in the development of metabolic disorders or rather is a marker for an unfavourable diet or hepatic insulin resistance.Keywords
This publication has 48 references indexed in Scilit:
- A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker ratsJournal of Lipid Research, 2010
- Combined Therapy of Dietary Fish Oil and Stearoyl-CoA Desaturase 1 Inhibition Prevents the Metabolic Syndrome and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Individual Stearoyl-CoA Desaturase 1 Expression Modulates Endoplasmic Reticulum Stress and Inflammation in Human Myotubes and Is Associated With Skeletal Muscle Lipid Storage and Insulin Sensitivity In VivoDiabetes, 2009
- Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver DiseaseJournal of Biological Chemistry, 2009
- Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty LiverDiabetes, 2009
- Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links to obesity and insulin resistanceLipids in Health and Disease, 2009
- Stearoyl-Coenzyme A Desaturase 1 Gene Expression Increases after Pioglitazone Treatment and Is Associated with Peroxisomal Proliferator-Activated Receptor-γ ResponsivenessThe Journal of Clinical Endocrinology & Metabolism, 2008
- Inhibition of Stearoyl-Coenzyme A Desaturase 1 Dissociates Insulin Resistance and Obesity From AtherosclerosisCirculation, 2008
- Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic MetabolismCell, 2008
- Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistanceJournal of Clinical Investigation, 2006